Brochure
16 Apr 2025

Embrace biosolutions today for a sustainable and competitive tomorrow

From concept to commercialization, Novonesis recombinant enzymes for fine chemicals provide a renewable and cost-efficient alternative to replace chemicals, metals, and solvents to improve processes cost-effectively by use of sustainable alternatives to chemicals for better quality APIs and intermediates. Partner with us to drive innovation in Pharma, diagnostics, cell culture, peptides, and regenerative medicine.

Content provided by our supplier

Novonesis

  • Country/Region:
    Denmark
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical

Other Content from Novonesis (1)